Scientist analyzing cannabis growing operation
(Source: Adobe Stock)
  • Xebra Brands (CSE:XBRA), the only company authorized to import seeds, cultivate, manufacture and sell cannabis in Mexico, expects to carry on with its North American growth strategy as planned, despite U.S. tariff pressures and global equity volatility
  • The company’s products are exempt from tariffs thanks to falling under the United States-Mexico-Canada Agreement
  • Xebra Brands is a cannabis company with a first-mover advantage in the Mexican market
  • Xebra Brands stock has given back 33.33 per cent year-over-year and over 87 per cent since 2021

Xebra Brands (CSE:XBRA), the only company authorized to import seeds, cultivate, manufacture and sell cannabis in Mexico, expects to carry on with its North American growth strategy as planned, despite U.S. tariff pressures and global equity volatility.

In Tuesday’s news release, the company notes that it is exempt from the universal 10 per cent tariff imposed by U.S. President Donald Trump because its products fall under the United States-Mexico-Canada Agreement (USMCA), which Trump has ratified.

Xebra expects the exemption to result in operational and cost stability for the sector, which may explain why, despite tariff headwinds and fears of inflation and recession, “North American cannabis-related equities have shown relative resilience, supported by investor optimism around domestic supply chain integration and regulatory tailwinds,” the news release continues.

The next step in Xebra’s growth strategy is an agricultural agreement, currently under negotiation with David Ross Macias Diaz, its largest shareholder, to use Diaz’s land in Mexico for cannabis cultivation under the company’s exclusive federal authorization. The agreement will be the first of its kind under Mexico’s federal cannabis law.

Xebra is also advancing its agreement with BSK to grow its e-commerce presence in Mexico and streamline U.S. entry for its Elements product line, furthering its goal of capitalizing on the integrated North American market.

Leadership insights

“Recent tariff clarity, coupled with broader market volatility, only reinforces our conviction in the North American strategy,” Rodrigo Gallardo, interim chief executive officer of Xebra Brands, said in a statement. “As global markets react to economic uncertainty, our foundation within the USMCA framework offers both security and opportunity. We’re strategically positioned to leverage that advantage across our operations.”

About Xebra Brands

Xebra Brands is a cannabis company with a first-mover advantage in the Mexican market.

Xebra Brands stock (CSE:XBRA) is unchanged trading at C$0.08 per share as of 9:50 am ET. The stock has given back 33.33 per cent year-over-year and over 87 per cent since 2021.

Join the discussion: Find out what everybody’s saying about this cannabis stock on the Xebra Brands Ltd. Bullboard and check out the rest of Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

(Top photo: Adobe Stock) 


More From The Market Online

@ the Bell: TSX hits new record high, only to close lower

Canada’s top stock index came out of the gate hot on Friday to close out the...

@ the Bell: Oracle’s earnings miss sparks tech selloff

Canada’s top stock index rallied on Thursday despite renewed concerns over inflated technology valuations—sparked by Oracle’s...

Market Open: Disney Pops on AI Deal, Broadcom Slides on Backlog Concerns | Dec 12

TSX rises 0.54%, Nasdaq falls 1.10%, gold hits two-month high, oil and Bitcoin drop. Disney gains on AI deal while Broadcom slides on backlog…
Cannabis leaves with Stock Talk and Cannabis Report labels

StockTalk | Cannabis Report: New stores, new shipments, new vapes

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks